Hikma Expands its Global Injectables Business - Live Webcast
October 29 2010 - 4:20AM
PR Newswire (US)
LONDON, October 29, 2010 /PRNewswire/ -- Hikma
Pharmaceuticals, the multinational pharmaceutical group, announces
that it has signed an agreement to acquire Baxter Healthcare
Corporation's US generic injectables business for a cash
consideration of $112 million.
There will be a live analyst and investor webcast outlining the
event on http://www.cantos.com at 0930
BST. An on-demand replay of the webcast will also be
available.
Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company
executives. If you would like to contact us, please email
amanda.alexander@cantos.com or phone +44-207-936-1352.
Copyright 2010 PR Newswire
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024